tip

tip

TIP A COLLEAGUE

Key publications

Efficacy within depression

A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.

Baldwin et al., Int Clin Psychopharmacol. 2006 May;21(3):159-69.

Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression

Bech et al., International Journal of Neuropsychopharmacology 2004; 7: 283-290

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder

Bielski et al., Journal of Clinical Psychiatry 2004; 65: 1190-1196

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Cipriani et al. Lancet 2009; 373 (9665): 746-758

Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder

Gorwood et al. Am J Geriatr Psychiatry 2007; 15(7): 581-593

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients

J.-P. Boulenger, Current Medical Research and Opinion Vol. 22, No. , 2006, 1331-1341

Superiority of escitalopram to paroxetine in the treatment of depression

Kasper et al Eur Neuropsychopharmacol 2009;(4):229-237

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy et al., J Psychiatry Neurosci. 2006 Mar;31(2):122-31.

Escitalopram in the treatment of major depressive disorder: A meta-analysis

Kennedy et al. Curr Med Res Opin 2009; 25(1): 161-175

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan et al. Clin Drug Investig. 2007;27(7):481-92.

Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials

Lam et al. Int Clin Psychopharmacol 2008;23:181-187

Comparison of escitalopram and citalopram in outpatients with severe major depressive disorder: a prospective, naturalistic, 8-week study.

Lancon et al, International Journal of Psychiatry in Clinical Practice 2006; 10(2): 131-137

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Lepola et al., International Clinical Psychopharmacology 2004, 19:149-155

Efficacy of escitalopram in patients with severe depression: a pooled analysis

Llorca, International Journal of Clinical Practice 2005; 59:268-275

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

Escitalopram versus venlafaxine XR in the treatment of depression.

Montgomery et al, Int Clin Psychopharmacol. 2006 Sep;21(5):297-309

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

Moore et al., International Clinical Psychopharmacology 2005; 20: 131-137

A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder.

Wade et al. Curr Med Res Opin. 2007 Jul;23(7):1605-14.

Published: 18/05/2006 Last updated: 27/07/2010

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us